yingchun jiang

Results-driven Biopharma R&D leader with 12+ years of end-to-end expertise across drug discovery, clinical development, regulatory strategy, and global commercialization. Equipped with a top-ranked UK Ph.D. in Pharmacy and a proven track record of leading high-performing teams, managing cross-functional R&D pipelines, and delivering impactful business outcomes—including 4 IND approvals, $15M+ in funding, and multi-million RMB technology transfers. A standout in overcoming CGT industry cross-border licensing barriers (technical/regulatory complexities) to secure agreements with 5 international pharmaceutical leaders. Specializes in CGT, CNS disorders, antiviral therapeutics, and CRISPR/high-throughput screening platforms. Adept at translating scientific insights into actionable strategies, navigating global regulations, and building academia-industry-government partnerships to drive innovation, R&D efficiency, and client-centric biopharma value chain optimization.